Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today ...
Morning Overview on MSN
This rare mutation destroys brain cells, scientists found the cause
Scientists have traced a devastating pattern of brain cell loss in a handful of families to a single, ultra-rare mutation ...
5don MSN
BRAF gene mutation leads to different therapeutic responses in melanoma and colorectal cancer
A review article led by researchers from the B·ARGO group at the Germans Trias i Pujol Research Institute (IGTP) and from the ...
Using menopausal hormone therapy (MHT) was not associated with an increased risk of breast cancer in women with inherited ...
Researchers discovered that a tiny structural feature of the enzyme GPX4 helps keep neurons safe. A rare mutation removes this protection, allowing harmful molecules to damage cell membranes and ...
Eight hundred and six patients were randomly assigned (2:1). Tumors were analyzed using the Myriad MyChoice HRD Plus assay to assess non–BRCA HRRm and HRD status; HRD was based on a genomic ...
Menopausal hormone therapy (MHT) does not raise breast cancer risk in women with breast cancer gene mutations, while estrogen only MHT leads to reduced risk.
Disruptions in transcriptional regulation during hematopoiesis can lead to abnormal hematopoietic differentiation and the development of leukemia. Understanding the underlying mechanisms of disease ...
Researchers discovered that tanning beds cause widespread, mutation-laden DNA damage across almost all skin, explaining the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback